<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-166364</identifier>
<setSpec>1131-3587</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Follow-up of patients in the chronic phase of coronary heart disease</dc:title>
<dc:description xml:lang="en">The management of chronic ischemic heart disease has advanced and mortality has decreased. However, despite improvements in diagnosis and therapy, angina may persist and have a serious effect on quality of life. The beneficial effects of the secondary prevention of cardiovascular disease on morbidity and mortality have been well established, but these benefits are frequently diminished by nonadherence, therapeutic inertia and social inequality. Patients with a history of ischemic heart disease are at an increased risk of a new coronary event, and systematic follow-up coupled to the use of risk markers that enable risk to be stratified could help us improve outcomes. Changing health-care needs, comorbidities and aging all increase costs in patients with chronic disease. In integrated-care models, the primary care team takes the leading role in monitoring and providing care for patients with stable disease, while the cardiologist acts as a consultant and deals with newly diagnosed conditions and with patients who need closer follow-up or special investigations (AU)</dc:description>
<dc:creator>Murga, Nekane</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En los últimos años, el manejo de la cardiopatía isquémica crónica ha mejorado y se ha reducido la mortalidad. A pesar de la optimización del diagnóstico y el tratamiento, la angina puede persistir y causar un grave impacto en la calidad de vida. Aunque los efectos beneficiosos de la prevención secundaria cardiovascular en cuanto a morbilidad y mortalidad se han demostrado ampliamente, la falta de adherencia a los tratamientos, la inercia terapéutica y la inequidad social son problemas frecuentes. Los pacientes con antecedentes de enfermedad coronaria tienen riesgo de padecer un nuevo evento coronario. El seguimiento sistemático y una correcta estratificación de riesgo pueden ayudar a mejorar los resultados (AU)</dc:description>
<dc:source>Rev. esp. cardiol. Supl. (Ed. impresa);13(supl.B): 35b-41b, 2013. graf, tab</dc:source>
<dc:identifier>ibc-166364</dc:identifier>
<dc:title xml:lang="es">Seguimiento del paciente en la fase crónica de la enfermedad coronaria</dc:title>
<dc:subject>^d30650^s22080</dc:subject>
<dc:subject>^d5932^s22066</dc:subject>
<dc:subject>^d9396^s22074</dc:subject>
<dc:subject>^d30652</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10221</dc:subject>
<dc:subject>^d3343^s22080</dc:subject>
<dc:subject>^d28563</dc:subject>
<dc:subject>^d54536^s22080</dc:subject>
<dc:subject>^d11756^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>201300</dc:date>
</metadata>
</record>
</ibecs-document>
